Prevents over-secretion of glucagon: Glucagon is a hormone that tells the liver to send more glucose into the bloodstream when blood sugar levels are low
The ideal candidate has undergone bariatric surgery at least one year prior, maintains a stable weight (even if higher than goal), demonstrates renewed appetite or eating behavior challenges, and has no contraindications like unresolved nutritional deficiencies
Consistent with the findings that intestinal AMPK, which mediates NAMPT activation, is impaired in glucose intolerance, HFD-induced obesity, and aging downregulates the major NAD + -generating enzymes, including NAMPT, and reduces intestinal NAD + levels [31,99,100]
1 syringe per injection
If your doctor refusal seems based on this philosophy rather than your specific medical situation, you have options
Hormonal effects related to IGF-1 and androgen sensitivity may play a role